Body S, Asgari K, Cheung T H C, Bezzina G, Fone K F C, Glennon J C, Bradshaw C M, Szabadi E
Psychopharmacology Section, Division of Psychiatry, University of Nottingham, UK.
Behav Processes. 2006 Feb 28;71(2-3):258-67. doi: 10.1016/j.beproc.2005.10.004. Epub 2005 Dec 1.
5-HT2 receptor stimulation alters temporal differentiation in free-operant timing schedules. The anatomical location of the receptor population responsible for this effect is unknown. We examined the effect of a 5-HT2 receptor agonist and antagonists, injected systemically and into the dorsal striatum, a region that is believed to play a major role in interval timing. Rats were trained under the free-operant psychophysical procedure to press levers A and B in 50s trials in which reinforcement was provided intermittently for responding on A in the first half, and B in the second half of the trial. Percent responding on B (%B) was recorded in successive 5s epochs of the trials; logistic functions were fitted to the data from each rat to derive timing indices (T50: time corresponding to %B = 50; Weber fraction: [T75-T25]/2T50, where T75 and T25 are the times corresponding to %B = 75 and %B = 25). Systemic treatment with the 5-HT(2A/2C) receptor agonist 2,5,-dimethoxy-4-iodo-amphetamine (DOI) (0.25 mg/kg, s.c.) reduced T50; the 5-HT2A receptor antagonist MDL-100907 (0.5 mg/kg, i.p.) did not affect performance, but completely blocked the effect of DOI. DOI (1 and 3 microg) injected bilaterally into the dorsal striatum did not alter T50. The effect of systemic treatment with DOI (0.25 mg/kg, s.c.) was not altered by intra-striatal injection of MDL-100907 (0.3 microg) or the 5-HT2C receptor antagonist RS-102221 (0.15 microg). The ability of systemically administered MDL-100907 to reverse DOI's effect on T50 confirms the sensitivity of temporal differentiation to 5-HT2A receptor stimulation. The failure of intra-striatal MDL-100907 to antagonize the effects of DOI suggests that 5-HT2A receptors in the dorsal striatum are unlikely to be primarily responsible for DOI's effects on timing. Furthermore, the results provide no evidence for a role of striatal 5-HT2C receptors in DOI's effect on timing.
5-羟色胺2(5-HT2)受体激动可改变自由操作定时程序中的时间辨别能力。负责此效应的受体群体的解剖位置尚不清楚。我们研究了5-HT2受体激动剂和拮抗剂经全身给药以及注入背侧纹状体(该区域被认为在间隔定时中起主要作用)后的效应。大鼠在自由操作心理物理学程序下接受训练,在50秒的试验中按压杠杆A和B,在前半段试验中对A的反应间歇性给予强化,后半段试验中对B的反应给予强化。在试验连续的5秒时段内记录对B的反应百分比(%B);对每只大鼠的数据拟合逻辑函数以得出定时指标(T50:对应%B = 50的时间;韦伯分数:[T75 - T25]/2T50,其中T75和T25分别是对应%B = 75和%B = 25的时间)。用5-HT(2A/2C)受体激动剂2,5-二甲氧基-4-碘苯丙胺(DOI)(0.25毫克/千克,皮下注射)进行全身治疗可降低T50;5-HT2A受体拮抗剂MDL-100907(0.5毫克/千克,腹腔注射)不影响行为表现,但完全阻断了DOI的效应。双侧注入背侧纹状体的DOI(1和3微克)未改变T50。纹状体内注射MDL-100907(0.3微克)或5-HT2C受体拮抗剂RS-102221(0.15微克)未改变经全身给予DOI(0.25毫克/千克,皮下注射)的效应。全身给予MDL-100907逆转DOI对T50影响的能力证实了时间辨别对5-HT2A受体激动的敏感性。纹状体内MDL-100907未能拮抗DOI的效应表明,背侧纹状体内的5-HT2A受体不太可能是DOI对定时产生效应的主要原因。此外,结果没有为纹状体5-HT2C受体在DOI对定时的效应中发挥作用提供证据。